Profilin2 is required for filamentous actin formation induced by human parainfluenza virus type 2.


Journal

Virology
ISSN: 1096-0341
Titre abrégé: Virology
Pays: United States
ID NLM: 0110674

Informations de publication

Date de publication:
07 2019
Historique:
received: 14 02 2019
revised: 09 05 2019
accepted: 23 05 2019
pubmed: 1 6 2019
medline: 5 11 2019
entrez: 1 6 2019
Statut: ppublish

Résumé

We previously reported that human parainfluenza virus type 2 (hPIV-2) promoted RhoA activation and subsequent filamentous actin (F-actin) formation. Actin-binding proteins, such as profilin and cofilin, are involved in the regulation of F-actin formation by RhoA signaling. In the present study, we identified profilin2 as a key molecule that is involved in hPIV-2-induced F-actin formation. Immunoprecipitation assays demonstrated that hPIV-2 V protein binds to profilin2 but not to profilin1. Mutation of Trp residues within C-terminal region of V protein abolished the binding capacity to profilin2. Depletion of profilin2 resulted in the inhibition of hPIV-2-induced F-actin formation and the suppression of hPIV-2 growth. Overexpression of wild type V but not Trp-mutated V protein reduced the quantity of actin co-immunoprecipitated with profilin2. Taken together, these results suggest that hPIV-2 V protein promotes F-actin formation by affecting actin-profilin2 interaction through its binding to profilin2.

Identifiants

pubmed: 31150988
pii: S0042-6822(19)30133-3
doi: 10.1016/j.virol.2019.05.013
pii:
doi:

Substances chimiques

Actins 0
Profilins 0
V protein, human parainfluenza virus type 1 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108-114

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Keisuke Ohta (K)

Department of Microbiology, School of Medicine, Wakayama Medical University, Japan.

Yusuke Matsumoto (Y)

Department of Microbiology, School of Medicine, Wakayama Medical University, Japan.

Machiko Nishio (M)

Department of Microbiology, School of Medicine, Wakayama Medical University, Japan. Electronic address: mnishio@wakayama-med.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH